NewsBenzinga미네랄리스 테라퓨틱스, 2상 Explore-CKD 임상시험이 1차 평가 지표 달성 발표···학술지 ‘키드니 인터내셔널’에 전체 결과 게재 미네랄리스 테라퓨틱스, 2상 Explore-CKD 임상시험이 1차 평가 지표 달성 발표···학술지 ‘키드니 인터내셔널’에 전체 결과 게재 Benzinga 2026.10.28 11:15 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report